Volume 72, Number 11, March 17, 2009
About this course
- Released: 03/16/2009
- Expires: 03/17/2011
Learning Objectives:
Upon completion of the article by Hattan et al., the participant should be able to:
• Discuss the clinical symptomatology and possible pathophysiology of restless legs syndrome (RLS)
• List the reasons for a false positive screen for restless legs syndrome among patients with or without neuropathy
• Describe the results from this study assessing whether peripheral neuropathy is associated with an increased risk of restless legs syndrome
• Discuss whether any subtype of peripheral neuropathy is associated with an increased risk of restless legs syndrome compared to controls, based on the results of this study
Core Competencies:
The article by Hattan et al. covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Wiendl and Hohlfeld, the participant should be able to:
• Discuss the results of recent head-to-head trials of interferon-beta and glatiramer acetate
• Describe the results of recent therapeutic trials of progressive MS
• List recently observed adverse reactions from recent therapies and therapeutic trials in MS
Core Competencies:
The article by Wiendl and Hohlfeld covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
